Another piece of the Zika puzzle: assessing the associated factors to microcephaly in a systematic review and meta-analysis.
Congenital Zika syndrome
Congenital disease
Microcephaly
Pregnancy
Risk factors
Systematic review
Zika virus
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
received:
01
10
2019
accepted:
18
05
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Although it is known that Zika virus (ZIKV) infection during pregnancy may lead to microcephaly in the fetus, the prognostic factors associated with this tragic disorder remain unclear. We conducted a systematic review and meta-analysis to assess the prognostic factors associated with the incidence of microcephaly in congenital ZIKV infection. We conducted a comprehensive search in Ovid MEDLINE, Ovid MEDLINE (R) Epub ahead of print, Embase, Embase Classic, Web of Science, CINAHL, Cochrane CENTRAL, LILACS, and various thesis databases to identify human studies reporting microcephaly associated with congenital ZIKV infection. We requested primary data from the authors of the included studies to calculate summary estimates and conduct the meta-analysis of the most prevalent factors. We screened 4106 titles and abstracts, and identified 12 studies for inclusion in the systematic review. The assessment of ZIKV infection and the definition of microcephaly varied among studies. A total of 6154 newborns/fetuses were enrolled; of those, 1120 (18.20%) had a diagnostic of ZIKV infection, of which 509 (45.45%) were diagnosed with microcephaly. Nine studies addressed the link between congenital ZIKV infection and neurological findings in newborns/fetuses. Half of the studies provided primary data. Three out of 11 factors of interest seem to be prognostic factors of microcephaly: infant's sex - males compared to females: Relative Risk (RR) 1.30, 95% Confidence Interval (95% CI) 1.14 to 1.49; the stage of pregnancy when infection occurred - infection in the first trimester of pregnancy compared to infection at other stages of pregnancy: RR 1.41, 95% CI 1.09 to 1.82; and asymptomatic infection compared to symptomatic infection during pregnancy: RR 0.68; 95% CI 0.60 to 0.77. Our findings support the female-biased resistance hypothesis and reinforce the risk associated with the stage of pregnancy when ZIKV infection occurs. Continued surveillance of ZIKV infection during pregnancy is needed to identify additional factors that could contribute to developing microcephaly in affected fetuses. This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO), registration no. CRD 42018088075.
Sections du résumé
BACKGROUND
BACKGROUND
Although it is known that Zika virus (ZIKV) infection during pregnancy may lead to microcephaly in the fetus, the prognostic factors associated with this tragic disorder remain unclear. We conducted a systematic review and meta-analysis to assess the prognostic factors associated with the incidence of microcephaly in congenital ZIKV infection.
METHODS
METHODS
We conducted a comprehensive search in Ovid MEDLINE, Ovid MEDLINE (R) Epub ahead of print, Embase, Embase Classic, Web of Science, CINAHL, Cochrane CENTRAL, LILACS, and various thesis databases to identify human studies reporting microcephaly associated with congenital ZIKV infection. We requested primary data from the authors of the included studies to calculate summary estimates and conduct the meta-analysis of the most prevalent factors.
RESULTS
RESULTS
We screened 4106 titles and abstracts, and identified 12 studies for inclusion in the systematic review. The assessment of ZIKV infection and the definition of microcephaly varied among studies. A total of 6154 newborns/fetuses were enrolled; of those, 1120 (18.20%) had a diagnostic of ZIKV infection, of which 509 (45.45%) were diagnosed with microcephaly. Nine studies addressed the link between congenital ZIKV infection and neurological findings in newborns/fetuses. Half of the studies provided primary data. Three out of 11 factors of interest seem to be prognostic factors of microcephaly: infant's sex - males compared to females: Relative Risk (RR) 1.30, 95% Confidence Interval (95% CI) 1.14 to 1.49; the stage of pregnancy when infection occurred - infection in the first trimester of pregnancy compared to infection at other stages of pregnancy: RR 1.41, 95% CI 1.09 to 1.82; and asymptomatic infection compared to symptomatic infection during pregnancy: RR 0.68; 95% CI 0.60 to 0.77.
CONCLUSION
CONCLUSIONS
Our findings support the female-biased resistance hypothesis and reinforce the risk associated with the stage of pregnancy when ZIKV infection occurs. Continued surveillance of ZIKV infection during pregnancy is needed to identify additional factors that could contribute to developing microcephaly in affected fetuses.
PROTOCOL REGISTRATION
BACKGROUND
This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO), registration no. CRD 42018088075.
Identifiants
pubmed: 32487247
doi: 10.1186/s12889-020-08946-5
pii: 10.1186/s12889-020-08946-5
pmc: PMC7266116
doi:
Types de publication
Comparative Study
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
827Subventions
Organisme : Ministério da Educação
ID : CAPES/PDSE 88881.133664/2016-01
Références
Am J Obstet Gynecol. 2018 Apr;218(4):440.e1-440.e36
pubmed: 29353032
Am J Epidemiol. 2019 Jan 1;188(1):206-213
pubmed: 30165474
Epidemiol Serv Saude. 2016 Oct-Dec;25(4):691-700
pubmed: 27869982
Childs Nerv Syst. 2018 Jan;34(1):63-71
pubmed: 29110197
PLoS Med. 2017 Jan 3;14(1):e1002203
pubmed: 28045901
PLoS One. 2016 Jul 11;11(7):e0158807
pubmed: 27398996
Clin Microbiol Infect. 2019 Feb;25(2):142-146
pubmed: 30553031
EMBO Mol Med. 2016 Mar 31;8(4):305-7
pubmed: 26976611
J Infect Dis. 2014 Jul 15;209 Suppl 3:S107-13
pubmed: 24966190
PLoS One. 2018 Aug 15;13(8):e0201452
pubmed: 30110370
J Gynecol Obstet Hum Reprod. 2019 Oct;48(8):649-652
pubmed: 30685427
PLoS Negl Trop Dis. 2016 May 17;10(5):e0004726
pubmed: 27186984
Expert Rev Anti Infect Ther. 2018 Mar;16(3):243-254
pubmed: 29415586
Lancet Child Adolesc Health. 2018 Mar;2(3):205-213
pubmed: 30169255
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Reprod Health. 2017 Feb 28;14(1):28
pubmed: 28241773
Paediatr Perinat Epidemiol. 2019 Jan;33(1):88-99
pubmed: 30516287
PLoS Negl Trop Dis. 2016 Dec 20;10(12):e0005262
pubmed: 27997547
Nature. 2017 Jun 15;546(7658):411-415
pubmed: 28538734
Arch Pathol Lab Med. 2017 Jan;141(1):26-32
pubmed: 27636525
Lancet. 2016 Aug 27;388(10047):891-7
pubmed: 27372398
Childs Nerv Syst. 2018 Jan;34(1):73-78
pubmed: 29127595
Front Pediatr. 2017 Jun 19;5:144
pubmed: 28674684
Lancet. 2016 May 21;387(10033):2125-2132
pubmed: 26993883
Arch Argent Pediatr. 2014 Jun;112(3):215-23
pubmed: 24862802
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):615-621
pubmed: 28617773
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Am J Public Health. 2016 Apr;106(4):606-12
pubmed: 26959260
PLoS One. 2013 Apr 24;8(4):e62390
pubmed: 23638062
N Engl J Med. 2016 Jul 7;375(1):1-4
pubmed: 27222919
Lancet Infect Dis. 2018 Mar;18(3):328-336
pubmed: 29242091
JAMA. 2017 Jan 3;317(1):59-68
pubmed: 27960197
Prenat Diagn. 2019 May;39(6):420-430
pubmed: 30866073
J Matern Fetal Neonatal Med. 2020 Jan;33(2):217-221
pubmed: 29886800
Best Pract Res Clin Obstet Gynaecol. 2016 Apr;32:39-49
pubmed: 26527304
Lancet. 2017 Aug 26;390(10097):861-870
pubmed: 28647172
Int J Mol Sci. 2017 Aug 05;18(8):
pubmed: 28783051
N Engl J Med. 2016 May 19;374(20):1981-7
pubmed: 27074377
Emerg Microbes Infect. 2016 Mar 16;5:e22
pubmed: 26980239
Clin Microbiol Rev. 2004 Jan;17(1):1-13
pubmed: 14726453
Lancet Child Adolesc Health. 2017 Sep;1(1):45-55
pubmed: 30169227
Birth Defects Res. 2017 Mar 15;109(5):363-371
pubmed: 28398684
Int J Environ Res Public Health. 2016 Oct 20;13(10):
pubmed: 27775637
AJNR Am J Neuroradiol. 2017 Jul;38(7):1427-1434
pubmed: 28522665
J Craniofac Surg. 2017 Jan;28(1):299-300
pubmed: 27941545
J Infect Chemother. 2018 Sep;24(9):702-706
pubmed: 29735300
BMC Med. 2014 Nov 27;12:220
pubmed: 25428603
PLoS One. 2016 Jan 25;11(1):e0147601
pubmed: 26808317
Bull World Health Organ. 2018 Jun 01;96(6):402-413D
pubmed: 29904223
Ultrasound Obstet Gynecol. 2016 Jan;47(1):6-7
pubmed: 26731034
J AAPOS. 2017 Aug;21(4):295-299.e2
pubmed: 28450178
Cureus. 2018 Sep 12;10(9):e3290
pubmed: 30443460
Clin Nurse Spec. 2016 Jul-Aug;30(4):194-7
pubmed: 27309781
Emerg Infect Dis. 2018 Jan;24(1):1-8
pubmed: 29260671
Ultrasound Obstet Gynecol. 2017 Jun;49(6):729-736
pubmed: 28078779
J Family Med Prim Care. 2016 Jul-Sep;5(3):523-527
pubmed: 28217576